Navigation Links
Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
Date:12/20/2007

-Five New Clinical Trial Sites Recently Initiated To Support Ongoing

Trials- -Clinical Data Expected in 2008 from Seven Ongoing or Planned Clinical

Trials, Including Four Phase II Trials in Major Disease Indications- -Revenues Plus Cash On-Hand Expected to Provide Sufficient Resources to

Advance Programs as Planned-

TUSTIN, Calif., Dec. 20 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today confirmed that its plans for advancing all three of its lead clinical programs in 2008 remain on track. The combination of revenues expected to be generated by Avid, the company's contract manufacturing subsidiary, plus the more than $26 million in cash on- hand reported as of October 31, 2007, should provide sufficient resources to advance these programs. To enhance enrollment rates and accelerate the generation of clinical data, Peregrine recently added additional clinical trial sites to all three of the core clinical programs.

"We believe data from our lead clinical programs will be the key value drivers for Peregrine in 2008, and I am pleased to report that our ambitious clinical plans for advancing all three anti-cancer and antiviral clinical programs in calendar year 2008 are proceeding as planned," said Peregrine president and CEO Steven W. King. "With at least seven clinical studies, including four Phase II trials, slated for 2008, we anticipate that the coming year will provide us with many opportunities to share clinical data with the medical community, potential partners and investors." <
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...at Economic Club of Canada , ...mbassador to Speak at Economic Club of Canada., , ...ernational Investment, and Chairman and CEO of the...avid Appia go to www.investinfrance.org . , , ,W...ress to discuss recent pro-business initiatives ad...
(Date:11/25/2009)...-ArdeaBiosciences,Inc.(Nasdaq: RDEA )announcedtoda...iveofficer,willpresentatthePiperJaffray21stAnnualH...ollows:,PiperJaffray21stAnnualHealthCareConferenc...Time,Location:TheNewYorkPalaceHotel,NewYork,NY,Web...arget=,_blank,title=,http://www.corporate-ir.net/i...
(Date:11/24/2009)...womoreprestigiousuniversitieshavejoinedBioCareerCe...eforlifescienceprofessionals. ,, Northwesternan...ing28othermajorlifesciencetrainingInstitutions. ,...rpost-graduatesinthelifesciences.Whiletherearehund...rCenteristheonlyonethatserveslifesciencepost-gradu...
(Date:11/24/2009)...e-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )t...nsbytheU.S.BankruptcyCourtfortheDistrictofDelaware...arypetitionfor,reliefunderChapter11oftheUnitedStat...eordersissuedbytheBankruptcyCourtallowthecompanyto...ceedings.Inparticular,the,companyreceivedinterimBa...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...- William R. Hendee will retire effective June 30 ...ces at the Medical College of Wisconsin , and dev...nal. , ,Hendee, who also will retire as president ...rement on June 19. While the Medical College condu... is likely to look inside the organization for int...
...e to the Wisconsin State Senate five years ago, ... done little to transform its economy from an old ...el favoring innovation and ideas. , ,Simply put, t... at the expense of creating new ones. The lack of ...f the line when it came to capital formation and j...
...mpanies that ranked among the best places to work ...eld are ranked highly because they offer employee ... job satisfaction. , , Northwestern Mutual Life I...ce Group , Madison, and Schneider National Inc. ,...f America,s top 100 companies complied by Compute...
Other Biology Technology:Medical College grad school dean Bill Hendee to retire 2It's time for Wisconsin's economy to grow 2It's time for Wisconsin's economy to grow 3Wisconsin companies among Best IT Workplaces 2
(Date:11/24/2009)...rican College of Medical Toxicology (ACMT) have si...n of the Journal of Medical Toxicology (JMT), th... 2010. It was previously published by the Univers...dical Toxicology , an international, peer-reviewed...d practice of medical toxicology. The quarterly j...
(Date:11/24/2009)...mber 24, 2009) New research on bacterial communit...eveals predictable temporal patterns, suggesting t...ers for monitoring climate change in the polar reg...edings of the National Academy of Sciences Early ...ix rivers shifted synchronously over time, correla...
(Date:11/23/2009)... November 23, 2009 Applied mathematicians dissec...ncifolia ), a characteristic long leaf with a sadd...along the edges. The simple cause of the lily,s fa...ing during differential growthwas revealed by usin...bons. , Haiyi Liang, a postdoctoral student at H...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Beazley Expands Healthcare Team with Appointment of Tom McNally 49634 1Beazley Expands Healthcare Team with Appointment of Tom McNally 49634 2Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 1Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 2Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 3Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 1Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 2
...in Barcelona, Spain purchased the Genomatix Genome...oftware GmbH. , GGA comprises purpose built high p...atabases and software providing a complete solutio...NGS) data after mapping to the genome. , "In rega...ed it to many colleagues," says Dr. Ramin Shiekhat...
...dence of pneumothorax (PTX), or collapsed lung, am...a has been reported to range from 13 50 percent, ... In people, PTX is reported to be the most prevent...cic ultrasound has been infrequently used as a non...ct PTX and other thoracic injuries in veterinary t...
...t lower, costs and very large reductions in greenh...uels. That,s one of the key take-home messages fro...s in America,s Energy Future (RBAEF)" in a special... , The journal believes that the collection, whi...dozen mature technology biomass refining scenarios...
Other Biology News:CRG buys Genomatix' Next Generation Sequencing analysis solution 2Novel veterinary procedure detecting life-threatening injuries touted 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 3
Apoptotic DNA Laddering Kit - Tissue Supplement from R&D Systems
Rabbit Anti-Human Amyloid Precursor Protein (KP1 Domain) Polyclonal Antibody, Unconjugated from AbD Serotec
Goat HRP-AEC Cell & Tissue Staining Kit from R&D Systems
CultureWell multislip cell culture system MSI-12 *plate and insert fifteen 12 mm coverslips per insert* *set of 10* from Molecular Probes (Invitrogen)
Biology Products: